Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amneal
Pharma
Teva notches loss in inhaler patent case against Amneal
After being called out on its intellectual property last year, Teva has fallen victim to the FTC's ongoing crusade against questionable drug patents.
Fraiser Kansteiner
Jun 12, 2024 9:35am
GSK, Amneal and Kaleo walk back patents after FTC's challenge
Dec 21, 2023 11:08am
Samsung, Olympus, Dr. Reddy's—Fierce Pharma Asia
Mar 3, 2023 9:45am
Several generics makers report shortages of Roche's Tamiflu
Dec 21, 2022 9:03am
Adderall supply problems now evident at 7 of 9 US suppliers
Oct 7, 2022 8:35am
AvKARE bottles mix antidepressant and ED med, triggering recall
Dec 14, 2020 10:10am
